Search, analyze & compare

My selected companies

Adjust valuation method
WatchlistNameTickerP/EP/SP/BEV/EbitdaROEROICRSISMA200DCFVolumeClosing price
-
Acorda Therapeutics IncACOR-0.020.00-0.0015.17-23.68%-32.12%0.00$1.17-$217.0011,993$0.258

Detail of Acorda Therapeutics Inc

 
CEO
Dr. Ron Cohen M.D.
Employees
102
Industry
Drug Manufacturers—Specialty & Generic
Sector
Healthcare
Market cap
$320,436

Company details

Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in adults with multiple sclerosis; and Inbrija, an inhaled levodopa for intermittent treatment of OFF periods in people with Parkinson's disease treated with a carbidopa/levodopa regimen. It also markets Ampyra as Fampyra in Europe, Asia, and the Americas. In addition, it has collaboration and license agreement with Biogen Inc. for the development and commercialization of Ampyra. The company was incorporated in 1995 and is headquartered in Pearl River, New York. On April 1, 2024, Acorda Therapeutics, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Southern District of New York.

Revenue
Cost of goods
Gross profit
OE
R&D
G&A
OTH
OI
OIE
PI
TAX
NI
Revenue (Rev)
$111.12M
Cost of goods (CoG)
-$14.25M
Gross profit (GP)
$96.87M
Operating expense (OE)
-$86.54M
Research and development (R&D)
-$5.35M
General and administrative (G&A)
-$93.74M
Other (OTH)
$12.55M
Operating income (OI)
-$20.43M
Other income expense (OIE)
-$30.70M
Pretax income (PI)
-$18.58M
Tax (TAX)
$2.63M
Net income (NI)
-$15.95M
Acorda Therapeutics Inc
ACOR • XNGS • US
$0.258
-9.64 (-97.39%)
Stock vs Industry average
  • Industry average

Negative values are hidden from the graph.
Trailing annual dividend rate
$0.00
Payout ratio
0.00%
EPS
-$16.84
Margin profit
-14.36%
52 week low
$0.258
52 week high
$17.50
50-day simple moving average
$0.00
200-day simple moving average
$1.17
Percent held by insiders
0.69%
Percent held by institutions
13.38%
Dividend yield
0.00%

Change of shares

Cash vs Debt

Insider Trading

Comparison of selected companies

 
%
Price change
ACOR -97.39%
eps change
ACOR 0.00%